Cell therapy for modification of the myocardial electrophysiological substrate

Circulation
Lior YankelsonLior Gepstein

Abstract

Traditional antiarrhythmic pharmacological therapies are limited by their global cardiac action, low efficacy, and significant proarrhythmic effects. We present a novel approach for the modification of the myocardial electrophysiological substrate using cell grafts genetically engineered to express specific ionic channels. To test the aforementioned concept, we performed ex vivo, in vivo, and computer simulation studies to determine the ability of fibroblasts transfected to express the voltage-sensitive potassium channel Kv1.3 to modify the local myocardial excitable properties. Coculturing of the transfected fibroblasts with neonatal rat ventricular myocyte cultures resulted in a significant reduction (68%) in the spontaneous beating frequency of the cultures compared with baseline values and cocultures seeded with naive fibroblasts. In vivo grafting of the transfected fibroblasts in the rat ventricular myocardium significantly prolonged the local effective refractory period from an initial value of 84+/-8 ms (cycle length, 200 ms) to 154+/-13 ms (P<0.01). Margatoxin partially reversed this effect (effective refractory period, 117+/-8 ms; P<0.01). In contrast, effective refractory period did not change in nontransplanted sites...Continue Reading

References

May 1, 1989·Pflügers Archiv : European journal of physiology·M B RookB de Jonge
Aug 1, 1995·Pacing and Clinical Electrophysiology : PACE·M M Scheinman
Aug 1, 1994·Biophysical Journal·S Marom, I B Levitan
Jan 11, 1996·The New England Journal of Medicine·F M Kusumoto, N Goldschlager
Sep 13, 2002·Nature·Junichiro MiakeH Bradley Nuss
Mar 5, 2003·Circulation·Jihong QuMichael R Rosen
Jun 5, 2003·Journal of Cardiovascular Electrophysiology·Gordon F Tomaselli, J Kevin Donahue
Aug 2, 2003·Circulation Research·Giedrius GaudesiusStephan Rohr
Mar 27, 2004·Physiological Reviews·André G Kléber, Yoram Rudy
Sep 27, 2005·Trends in Cardiovascular Medicine·J Kevin DonahueTetsuo Sasano
Feb 18, 2006·Circulation Research·Michele MiragoliStephan Rohr
Jul 17, 2007·Medical & Biological Engineering & Computing·Michael R RosenRichard B Robinson

❮ Previous
Next ❯

Citations

Dec 17, 2010·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Gerard J J Boink, Michael R Rosen
Aug 26, 2011·Journal of Cardiovascular Translational Research·Fernando TondatoNicholas S Peters
Mar 1, 2012·Cardiovascular Research·Gerard J J BoinkMichael R Rosen
Nov 1, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Robert D Kirkton, Nenad Bursac
Sep 23, 2008·Journal of Cardiovascular Pharmacology·Guy AmitJ Kevin Donahue
Feb 18, 2011·Journal of Cardiovascular Pharmacology·Stephan Rohr
Nov 22, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Jennifer R BaumHeather S Duffy
Jun 23, 2012·Circulation. Arrhythmia and Electrophysiology·Gerard J J BoinkMichael R Rosen
Jul 12, 2012·Journal of Geriatric Cardiology : JGC·Yong-Fu Xiao
Jan 10, 2014·Current Opinion in Nephrology and Hypertension·Barbara SchreierClaudia Grossmann
Feb 13, 2014·Cardiovascular Research·Udi NussinovitchLior Gepstein
Aug 21, 2013·Current Cardiology Reports·Evgeny PokushalovJonathan S Steinberg
Aug 14, 2009·Expert Review of Cardiovascular Therapy·Sabine Telemaque, James D Marsh
Jan 19, 2016·Trends in Molecular Medicine·Eva A Rog-ZielinskaRoger Markwald
Jan 18, 2016·Journal of Molecular and Cellular Cardiology·Emily Ongstad, Peter Kohl
Dec 27, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Leonid Maizels, Lior Gepstein
Oct 19, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Anat HofshiLior Gepstein
Dec 1, 2015·Progress in Biophysics and Molecular Biology·Jeffrey W HolmesLior Gepstein
Mar 6, 2010·Annals of the New York Academy of Sciences·Lior Gepstein
Jan 12, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Carolyn A HolladayAbhay Pandit
Jan 15, 2014·Journal of Molecular and Cellular Cardiology·Peter Kohl, Robert G Gourdie
Aug 1, 2015·BioMed Research International·Michele Miragoli, Alexey V Glukhov
Feb 10, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Lior Gepstein
Aug 26, 2014·Frontiers in Physiology·Jussi T KoivumäkiWayne R Giles
May 29, 2016·Seminars in Cell & Developmental Biology·Emily L Ongstad, Robert G Gourdie
Jun 25, 2016·Nature Reviews. Drug Discovery·Robert G GourdiePeter Kohl
Mar 25, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Candido Cabo
Apr 22, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Helen E DriessenGerard J J Boink
Jan 10, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Amit GruberLior Gepstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.